Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC011309 | Panoply™ Human PARL Knockdown Stable Cell Line | Inquiry |
| CSC-SC011309 | Panoply™ Human PARL Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1268 | Human PARL Knockout Cell Line-HEK293T | Inquiry |
| CLKO-1121 | PARL KO Cell Lysate-HEK293T | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD11817Z | Human PARL adenoviral particles | Inquiry |
| LV20995L | human PARL (NM_001037639) lentivirus particles | Inquiry |
| LV20996L | human PARL (NM_018622) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHR088220 | shRNA set against Human PARL(NM_018622.5) | Inquiry |
| SHH370764 | shRNA set against Human PARL (NM_018622.5) | Inquiry |
| SHH370768 | shRNA set against Mouse PARL (NM_001005767.4) | Inquiry |
| SHH370772 | shRNA set against Rat PARL (NM_001035249.1) | Inquiry |
| SHR088216 | shRNA set against Mouse Parl(NM_001005767.4) | Inquiry |
| SHR088238 | shRNA set against Human PARL(NM_001037639.1) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCS406911 | Human PARL ORF Clone (BC014058) | Inquiry |
| CDCS406912 | Human PARL ORF Clone (BC003653) | Inquiry |
| CDFH013709 | Human PARL cDNA Clone(NM_001037639.1) | Inquiry |
| CDFR004459 | Rat Parl cDNA Clone(NM_001035249.1) | Inquiry |
| MiUTR1H-07516 | PARL miRNA 3'UTR clone | Inquiry |
| MiUTR1M-08906 | PARL miRNA 3'UTR clone | Inquiry |
| MiUTR1R-06122 | PARL miRNA 3'UTR clone | Inquiry |
| MiUTR3H-09512 | PARL miRNA 3'UTR clone | Inquiry |
| CDCB187069 | Rabbit PARL ORF clone (XM_002716489.2) | Inquiry |
| CDCH017020 | Mouse PARL ORF clone(NM_001005767.4) | Inquiry |
| CDCL145997 | Human PARL ORF clone (NM_018622.5) | Inquiry |
| CDCR343506 | Human PARL ORF Clone(NM_001037639.1) | Inquiry |
| CDCR371146 | Rat Parl ORF Clone(NM_001035249.1) | Inquiry |
The mitochondrial inner membrane rhomboid peptidase PARL is known to be involved in critical signaling cascades, but its role in the way to apoptosis is still not fully understood. In recent studies, PARL was demonstrated to be able to process the mitochondrial pro-apoptotic protein Smac, which can antagonize XIAP-mediated caspase inhibition since its release into the cytosol, to promote apoptosis. Within transmembrane domains, the mitochondrial intramembrane peptidase PARL cleaves its substrates to take part in crucial mitochondrial signaling cascades, including mitophagy via processing of the PINK1 and PGAM5, in detail, PINK1 topogenesis between the inner and outer mitochondrial membranes were controlled and CJs were stabilized via OPA1 processing to hinder apoptosis. Proteomic approaches were used to search for PARL substrates in wild-type and PARL knockout human cells, and mitochondrial proteins Smac, TTC19, CLPB and STARD7, the previously established substrates PINK1 and PGAM5, were identified. The functional and mechanistic characterization of PARL-dependent processing of the mitochondrial IM protein Smac was demonstrated to be a pro-apoptotic protein, which is released into the cytosol to relieve caspase activities from the XIAP inhibition for apoptosis. Bax-Bak-induced MOMP mediates the PARL-cleaved Smac fragment releasing into the cytosol. This processing was found to able to allow the Smac fragment bind to XIAP to prevent XIAP-mediated caspase inhibition by generating an N-terminal XIAP-binding motif.
In vitro assays of the mitochondrial intramembrane rhomboid protease PARL, it has been confirmed to be implicated in diverse functions, while its physiological role in vivo remains unclear. Nervous system conditional PARL deficient mice have a similarity with germline Parl KOs in phenotype, outlining the significance of PARL in neurological homeostasis. More than this, modification of this severe neurological phenotype cannot occur after genetically modifying the two major PARL substrates, PINK1 and PGAMS. Four factors can answer how Parl-/- brain mitochondria are affected, including progressive ultrastructural changes, defects in complex III (CIII) activity, coenzyme Q (CoQ) biosynthesis, and mitochondrial calcium metabolism. PARL works as a necessity for the stable expression of TTC19, which is required for CIII activity, and of COQ4, to function in CoQ biosynthesis. Maintenance of the respiratory chain in the nervous system partially relies on the function of PARL, deficiency of which causes progressive mitochondrial dysfunction and structural abnormalities, giving rise to neuronal necrosis and leigh-like syndrome.
Figure 1. PARL protease: A glimpse at intramembrane proteolysis in the inner mitochondrial membrane. (Laine Lysyk, et al. 2020)
References: